Novak Djokovic has a majority stake in a Danish biotechnology firm attempting to develop a treatment for Covid-19, the London Independent has reported.
Djokovic is now back in Serbia after being deported from Australia on Sunday for failing to meet the country’s tough Covid immigration laws.
QuantBioRes boss Ivan Loncarevic has revealed that the tennis player’s acquisition of an 80 per cent stake was made in June 2020.
The company is developing a peptide, which inhibits the virus from infecting the human cell, and expects to launch clinical trials later this year.
The CEO told the media organisation the company had about a dozen researchers working in Denmark, Australia and Slovenia.
Djokovic and his wife Jelena own 40.8 per cent and 39.2 per cent of the company, respectively.
Team GB pulled off a 3–1 victory over Australia in the Billie Jean King Cup…
Jannik Sinner will take back the No. 1 ranking on Monday after winning his fourth…
Novak Djokovic has been making it plain that the end of his career is approaching,…
Jannik Sinner and Carlos Alcaraz fulfilled expectations on Saturday as the top pair in the…
Jannik Sinner put pure power on display Saturday as the Italian reached his first Monte Carlo…
Carlos Alcaraz earned the 300th win of his ATP career as the Spaniard rolled 6-3,…